¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

(¿Â¶óÀÎ) 2020 Á¦ 16Â÷ ´ëÇѹé½ÅÇÐȸ ÃᡤÃß°èÇмú´ëȸ : 2020-09-18

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
(¿Â¶óÀÎ) 2020 Á¦ 16Â÷ ´ëÇѹé½ÅÇÐȸ ÃᡤÃß°èÇмú´ëȸ : 2020-09-18
±³À°ÀÏÀÚ : 2020-09-18
±³À°Àå¼Ò : ¿Â¶óÀÎ ¿¬¼ö±³À°  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2020 Á¦ 16Â÷ ´ëÇѹé½ÅÇÐȸ ÃᡤÃß°èÇмú´ëȸ      
ÁÖÃÖ±â°ü : ´ëÇѹé½ÅÇÐȸ
´ã´çÀÚ : ÃÖ¼ö¿¬ 
¿¬¶ôó : 02-740-8364  
À̸ÞÀÏ : office@korvac.org      
±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, »êºÎÀΰú, À̺ñÀÎÈÄ°ú, °¡Á¤ÀÇÇаú¿¹¹æÀÇÇÐ, ºÐÀÚ»ý¹°ÇÐ, ¹Ì»ý¹°ÇÐ,      
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 20ºÐ  
¼¼ºÎ¼ö°­·á : 100,000¿ø      
ºñ°í ¢º ȸ¿ø 1)Àü¹®ÀÇ,¹Ú»ç±Þ ÀÌ»ó ¼±ÀÓ ¹× Ã¥ÀÓ¿¬±¸ÀÚ: »çÀüµî·Ï 5¸¸¿ø/»çÀüµî·ÏÀÌÈĵî·Ï 7¸¸¿ø 2) Àü°øÀÇ, ´ëÇлý, ´ëÇпø»ý ¹× ¼®»ç±Þ ÀÌÇÏ ¿¬±¸¿ø: »çÀüµî·Ï 3¸¸¿ø/»çÀüµî·ÏÀÌÈĵî·Ï 5¸¸¿ø ¢º ºñȸ¿ø: »çÀüµî·Ï 8¸¸¿ø/»çÀüµî·ÏÀÌÈĵî·Ï 10¸¸¿ø ¢º ÇöÀåµî·Ï ºÒ°¡      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 09¿ù 18ÀÏ ¿Â¶óÀΠ09:00~09:00 Opening  () 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ09:00~09:25 Humoral immune response against COVID-19:long-term immunity and antibody dependent immune enhancement  ¹Ú¿Ï¹ü(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ09:25~09:50 Innate and T-cell immune response: perspectives on COVID-19 severity  ½ÅÀÇö(Ä«À̽ºÆ®) 
Åä·Ð 09¿ù 18ÀÏ ¿Â¶óÀΠ09:50~10:00 Q&A  () 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ10:00~10:25 µ¿¹°¿¡¼­ SARS-CoV-2 °Ë»ç¿Í Æò°¡  À¯±¤¼ö(ÀüºÏ´ë Àμö°øÅëÀü¿°º´¿¬±¸¼Ò) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ10:25~10:50 Animal models for COVID-19 vaccine  ÃÖ¿µ±â(ÃæºÏ´ë) 
Åä·Ð 09¿ù 18ÀÏ ¿Â¶óÀΠ10:50~11:00 Q&A  () 
È޽Ġ09¿ù 18ÀÏ ¿Â¶óÀΠ11:00~11:10 Coffee break  () 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ11:10~11:40 Global COVID-19 vaccine roadmap  Áö¿µ¹Ì(¼­¿ï´ë) 
±âŸ 09¿ù 18ÀÏ ¿Â¶óÀΠ11:40~12:00 ´ëÇѹé½ÅÇÐȸ ÆòÀÇ¿øȸ/ÃÑȸ  () 
½Ä»ç 09¿ù 18ÀÏ ¿Â¶óÀΠ12:00~13:00 e-Poster round & Lunch  () 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ13:00~13:25 DNA/mRNA-based COVID-19 vaccine  ¹Ú¼öÇü(Ä«À̽ºÆ®) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ13:25~13:50 Adenovirus-vectored COVID-19 vaccine  °­Ã¢À²(¼­¿ï´ë) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ13:50~14:15 Recombinant subunit COVID-19 vaccine  ±èÈÆ(SK bioscience) 
Åä·Ð 09¿ù 18ÀÏ ¿Â¶óÀΠ14:15~14:25 Q&A  () 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ14:25~14:55 Immune responses in children with COVID-19  ±è¿¹Áø(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ14:55~15:15 Multi-system inflammatory syndrome and COVID-19  Á¶Àº¿µ(Ãæ³²ÀÇ´ë) 
È޽Ġ09¿ù 18ÀÏ ¿Â¶óÀΠ15:15~15:25 Coffee break  () 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ15:25~15:50 Evaluation criteria and rapid approval plan for COVID-19 vaccine clinical trials  ±èµµ±Ù(KFDA) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ15:50~16:15 ModelingÀ» ÅëÇÑ ¹é½Å È¿°ú ¿¹Ãø  Á¤Àº¿Á(°Ç±¹´ë) 
±³À°½Ã°£ 09¿ù 18ÀÏ ¿Â¶óÀΠ16:15~16:40 Consideration of priority for COVID-19 vaccination  Á¤ÈñÁø(°í·ÁÀÇ´ë) 
Åä·Ð 09¿ù 18ÀÏ ¿Â¶óÀΠ16:40~17:00 Panel discussion – KFDA, KCDC  () 
±âŸ 09¿ù 18ÀÏ ¿Â¶óÀΠ17:00~17:00 Closing  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" (¿Â¶óÀÎ) 2020 Á¦ 16Â÷ ´ëÇѹé½ÅÇÐȸ ÃᡤÃß°èÇмú´ëȸ : 2020-09-18""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) ´ëÇѼö¸éÀÇÇÐȸ Á¦54Â÷ Ãß°èÇмú´ëȸ : 2020-09-18
´ÙÀ½±Û ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2020-09-17
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20790 °æ±â ´ëÇÑÇǺΰúÇÐȸ Á¦52Â÷ ÀÎõºÎõÁöºÎȸ ÇмúÁý´ãȸ : 2024-06-15 0 3 2024-05-27
20789 ¼­¿ï 2024³â ´ëÇѽŰæ±ÙÀ°ÁúȯÇÐȸ ¿¬¼ö°­Á : 2024-06-15 0 6 2024-05-27
20788 Á¦ÁÖ ´ëÇѳ»ºÐºñÇÐȸ Á¦22ȸ ºÐ°úÀü¹®ÀÇ ¿¬¼ö°­Á : 2024-06-15 0 4 2024-05-27
20787 Ãæ³² (¿Â¶óÀÎ)2024³âµµ Ãæû³²µµÀÇ»çȸ Ãá°èÇмú´ëȸ : 2024-06-15 0 5 2024-05-27
20786 ºÎ»ê KSMO ºÎ»ê¿ï»ê°æ³²/´ë±¸°æºÏÁöȸ °øµ¿ ½ÉÆ÷Áö¾ö : 2024-06-14 0 4 2024-05-27
20785 ¼­¿ï 2024³â ´ëÇѺҾÈÀÇÇÐȸ Ãá°èÇмú´ëȸ (´Ù½Ã, °Ü¿ï³ª¹«¿¡¼­ º½ ³ª¹«¿¡·Î From Traditional approaches to Innovation in Psychiatry) : 2024-06-14 0 7 2024-05-27
20784 ¼­¿ï ´ëÇÑ°áÇÙÇùȸ 2024³â °áÇÙ°ü¸®±³À° 1±â(2ÀÏÂ÷) : 2024-06-14 0 4 2024-05-27
20783 ¼­¿ï Á¦14Â÷ Çѱ¹ÃÖ¼Òħ½ÀÃéÀå¼ö¼ú¿¬±¸È¸ : 2024-06-14 0 3 2024-05-27
20782 ´ëÀü 2024 Á¦40ȸ ´ëÇѼҾƿܰúÇÐȸ Ãá°èÇмú´ëȸ ¹× 40Áֳ⠱â³äÇà»ç (2ÀÏÂ÷) : 2024-06-14 0 5 2024-05-27
20781 ´ë±¸ Ä¥°î°æºÏ´ëÇб³º´¿ø RARE DISEASE SYMPOSIUM 2024 : 2024-06-14 0 2 2024-05-27
20780 ºÎ»ê 2024 ´ëÇѽŰæ¿Ü°úÇÐȸ ºÎ»ê¿ï»ê°æ³²Áöȸ Á¦2Â÷ Á¤±âÇмú´ëȸ : 2024-06-14 0 5 2024-05-27
20779 ¼­¿ï 2024 ´ëÇÑÀÇÇÐȸ Çмú´ëȸ : 2024-06-14 0 5 2024-05-27
20778 ¼­¿ï ´ëÇÑÁø´ÜÀ¯ÀüÇÐȸ 2024³â Á¦19Â÷ Çмú´ëȸ (2ÀÏÂ÷) : 2024-06-14 0 7 2024-05-27
20777 ¼­¿ï 2024 ´ëÇÑÈ­»óÇÐȸ Çмú´ëȸ(2ÀÏÂ÷) : 2024-06-14 0 5 2024-05-27
20776 ºÎ»ê 2024³â Çѱ¹°£´ãÃé¿Ü°úÇÐȸ ºÎ¿ï°æÁöȸ °£ÀÌ½Ä ½ÉÆ÷Áö¾ö : 2024-06-14 0 5 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷